Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,454,328 shares
Ownership 1.80%
Morgan Stanley ownership in NVAX / Novavax, Inc.

2024-03-07 - Morgan Stanley has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,454,328 shares of Novavax, Inc. (CH:NVAX). This represents 1.8 percent ownership of the company. In their previous filing dated 2024-02-09 , Morgan Stanley had reported owning 7,308,033 shares, indicating a decrease of -66.42 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-03-07 2024-03-07 13G/A 7,308,033 2,454,328 -66.42 1.80 -70.97
2024-02-09 2024-02-09 13G 7,308,033 6.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVAVAX COM NEW 670002401 572,034 -3,145,950 -84.61 4,656 -81.36 0.0003
2026-05-27 2025-12-31 13F/A-1 NOVAVAX COM NEW 670002401 3,717,984 2,641,540 245.40 24,985 167.72 0.0015
2026-02-13 2025-12-31 13F NOVAVAX COM NEW 670002401 3,717,984 2,641,540 24,985 0.0015
2026-05-27 2025-09-30 13F/A-1 NOVAVAX COM NEW 670002401 1,076,444 -162,342 -13.10 9,333 19.58 0.0006
2025-11-14 2025-09-30 13F NOVAVAX COM NEW 670002401 1,076,444 -162,342 9,333 0.0006
2025-08-15 2025-06-30 13F NOVAVAX COM NEW 670002401 1,238,786 -739,154 -37.37 7,804 -38.44 0.0005
2025-05-15 2025-03-31 13F NOVAVAX COM NEW 670002401 1,977,940 -2,962,175 -59.96 12,679 -68.08 0.0009
2025-05-15 2024-12-31 13F/A-1 NOVAVAX COM NEW 670002401 4,940,115 3,387,896 218.26 39,719 102.60 0.0028
2025-02-14 2024-12-31 13F NOVAVAX COM NEW 670002401 4,940,115 3,387,896 39,719 0.0028
2025-05-14 2024-09-30 13F/A-2 NOVAVAX COM NEW 670002401 1,552,219 -150,516 -8.84 19,605 -9.06 0.0014
2025-02-14 2024-09-30 13F/A-1 NOVAVAX COM NEW 670002401 1,552,219 -150,516 19,605 0.0014
2024-11-14 2024-09-30 13F NOVAVAX COM NEW 670002401 1,552,219 -150,516 19,605 0.0014
2025-05-14 2024-06-30 13F/A-2 NOVAVAX COM NEW 670002401 1,702,735 -167,595 -8.96 21,557 141.12 0.0017
2024-10-17 2024-06-30 13F/A-1 NOVAVAX COM NEW 670002401 1,702,735 -167,595 21,557 0.0017
2024-08-14 2024-06-30 13F NOVAVAX COM NEW 670002401 1,702,735 -167,595 21,557 0.0017
2024-10-17 2024-03-31 13F/A-2 NOVAVAX COM NEW 670002401 1,870,330 -5,371,125 -74.17 8,940 -74.28 0.0007
2024-08-16 2024-03-31 13F/A-1 NOVAVAX COM NEW 670002401 1,870,330 -5,371,125 8,940 0.0007
2024-05-15 2024-03-31 13F NOVAVAX COM NEW 670002401 1,870,330 -5,371,125 8,940 0.0007
2024-08-16 2023-12-31 13F/A-1 NOVAVAX COM NEW 670002401 7,241,455 4,966,324 218.29 34,759 111.03 0.0031
2024-02-13 2023-12-31 13F NOVAVAX COM NEW 670002401 7,241,455 4,966,324 34,759 0.0031
2023-11-15 2023-09-30 13F NOVAVAX COM NEW 670002401 2,275,131 194,694 9.36 16,472 6.56 0.0017
2023-08-14 2023-06-30 13F NOVAVAX COM NEW 670002401 2,080,437 -373,402 -15.22 15,458 -9.10 0.0015
2023-05-15 2023-03-31 13F NOVAVAX COM NEW 670002401 2,453,839 674,445 37.90 17,005 -7.04 0.0018
2023-02-14 2022-12-31 13F NOVAVAX COM NEW 670002401 1,779,394 685,214 62.62 18,292 -8.14 0.0021
2022-11-14 2022-09-30 13F NOVAVAX COM NEW 670002401 1,094,180 -192,009 -14.93 19,913 -69.90 0.0027
2022-10-27 2022-06-30 13F/A-1 NOVAVAX COM NEW 670002401 1,286,189 383,415 42.47 66,149 -0.51 0.0086
2022-08-15 2022-06-30 13F NOVAVAX COM NEW 670002401 1,286,189 383,415 66,149 0.0086
2022-10-27 2022-03-31 13F/A-1 NOVAVAX COM NEW 670002401 902,774 -53,718 -5.62 66,490 -51.41 0.0090
2022-05-13 2022-03-31 13F NOVAVAX COM NEW 670002401 902,774 -53,718 66,490 0.0090
2022-02-14 2021-12-31 13F NOVAVAX COM NEW 670002401 956,492 270,868 39.51 136,845 -3.72 0.0169
2021-11-15 2021-09-30 13F NOVAVAX COM NEW 670002401 685,624 215,448 45.82 142,138 42.39 0.0191
2021-08-23 2021-06-30 13F/A-1 NOVAVAX COM NEW 670002401 470,176 183,024 63.74 99,823 91.74 0.0132
2021-08-16 2021-06-30 13F NOVAVAX COM NEW 670002401 470,176 183,024 99,823 0.0131
2021-05-17 2021-03-31 13F NOVAVAX COM NEW 670002401 287,152 -61,431 -17.62 52,063 33.94 0.0076
2021-02-16 2020-12-31 13F NOVAVAX COM NEW 670002401 348,583 -115,415 -24.87 38,871 -22.68 0.0060
2020-11-13 2020-09-30 13F NOVAVAX COM NEW 670002401 463,998 215,103 86.42 50,274 142.33 0.0097
2020-08-14 2020-06-30 13F NOVAVAX COM NEW 670002401 248,895 -187,576 -42.98 20,746 249.97 0.0046
2020-05-26 2020-03-31 13F/A-1 NOVAVAX COM NEW 670002401 436,471 307,875 239.41 5,928 1,060.08 0.0016
2020-05-15 2020-03-31 13F NOVAVAX COM NEW 670002401 436,471 307,875 5,928 1,608.0375
2020-02-14 2019-12-31 13F NOVAVAX COM NEW 670002401 128,596 -365,083 -73.95 511 -79.38 0.0001
2019-11-14 2019-09-30 13F NOVAVAX COM NEW 670002401 493,679 -160,288 -24.51 2,478 -35.32 0.0007
2019-08-14 2019-06-30 13F NOVAVAX COM NEW 670002401 653,967 -4,645,634 -87.66 3,831 31.20 0.0010
2019-05-15 2019-03-31 13F NOVAVAX COM 670002104 5,299,601 1,280,724 31.87 2,920 -60.51 0.0008
2019-02-14 2018-12-31 13F NOVAVAX COM 670002104 4,018,877 538,464 15.47 7,394 13.01 0.0022
2019-04-23 2018-09-30 13F/A-2 NOVAVAX COM 670002104 3,480,413 -2,792,260 -44.51 6,543 -22.16 0.0016
2018-11-20 2018-09-30 13F/A-1 NOVAVAX COM 670002104 3,480,413 0 6,543 0.0016
2018-11-14 2018-09-30 13F NOVAVAX COM 670002104 3,480,413 -2,792,260 6,543
2019-04-23 2018-06-30 13F/A-1 NOVAVAX COM 670002104 6,272,673 3,596,645 134.40 8,406 49.60 0.0023
2018-08-14 2018-06-30 13F NOVAVAX COM 670002104 6,272,673 3,596,645 8,406
2019-04-23 2018-03-31 13F/A-1 NOVAVAX COM 670002104 2,676,028 -214,852 -7.43 5,619 56.78 0.0016
2018-05-14 2018-03-31 13F NOVAVAX COM 670002104 2,676,028 -214,852 5,619
2019-04-23 2017-12-31 13F/A-1 NOVAVAX COM 670002104 2,890,880 -180,068 -5.86 3,584 2.34 0.0010
2018-02-14 2017-12-31 13F NOVAVAX COM 670002104 2,890,880 -180,068 3,584
2017-11-14 2017-09-30 13F NOVAVAX COM 670002104 3,070,948 15,981 0.52 3,502 -0.31 0.0010
2017-08-11 2017-06-30 13F NOVAVAX COM 670002104 3,054,967 -92,004 -2.92 3,513 -12.79 0.0011
2017-05-22 2017-03-31 13F/A-1 NOVAVAX COM 670002104 3,146,971 -212,957 -6.34 4,028 -4.84 0.0012
2017-05-12 2017-03-31 13F NOVAVAX COM 670002104 3,146,971 4,028
2017-02-22 2016-12-31 13F/A-1 NOVAVAX COM 670002104 3,359,928 434,472 14.85 4,233 -30.45 0.0014
2017-02-13 2016-12-31 13F NOVAVAX COM 670002104 3,359,928 4,233
2016-11-10 2016-09-30 13F NOVAVAX COM 670002104 2,925,456 169,893 6.17 6,086 -69.62 0.0021
2016-08-12 2016-06-30 13F NOVAVAX COM 670002104 2,755,563 -637,504 -18.79 20,032 14.42 0.0072
2016-05-12 2016-03-31 13F NOVAVAX COM 670002104 3,393,067 2,254,705 198.07 17,508 83.33 0.0067
2016-02-09 2015-12-31 13F NOVAVAX COM 670002104 1,138,362 -164,977 -12.66 9,550 3.64 0.0035
2016-02-08 2015-09-30 13F/A-1 NOVAVAX COM 670002104 1,303,339 -138,371 -9.60 9,215 -42.62 0.0034
2015-11-09 2015-09-30 13F NOVAVAX COM 670002104 1,303,339 9,215
2015-08-12 2015-06-30 13F NOVAVAX COM 670002104 1,441,710 -118,820 -7.61 16,060 24.45 0.0056
2015-05-14 2015-03-31 13F NOVAVAX COM 670002104 1,560,530 179,841 13.03 12,905 57.61 0.0048
2015-02-13 2014-12-31 13F NOVAVAX COM 670002104 1,380,689 -20,882 -1.49 8,188 40.11 0.0030
2014-12-16 2014-09-30 13F/A-1 NOVAVAX COM 670002104 1,401,571 916,295 188.82 5,844 165.76 0.0022
2014-11-14 2014-09-30 13F NOVAVAX COM 670002104 1,401,571 5,844
2014-05-13 2014-03-31 13F NOVAVAX COM 670002104 485,276 115,416 31.21 2,199 16.10 0.0009
2014-02-13 2013-12-31 13F NOVAVAX COM 670002104 369,860 -456,138 -55.22 1,894 -27.21 0.0008
2013-11-13 2013-09-30 13F NOVAVAX INC COM ST COM 670002104 825,998 686,811 493.44 2,602 812.98 0.0012
2013-08-08 2013-06-30 13F NOVAVAX INC COM ST COM 670002104 139,187 139,187 285 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.